Senyo Health With Substance Use Disorder (SUD) In Primary Care

Overview

About this study

The purpose of this study is to examine the barriers, facilitators, and optimal processes for implementing a digitally enhanced screening, brief intervention, and referral to treatment (SBIRT) model for Substance Use Disorder SUD treatment among Mayo primary care clinics.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

* Ability to read, write, and understand English
* Minimum DAST (1+), audit-C score (3+)
* Access and willingness to use a mobile device for asynchronous (text) and synchronous (video) engagement with care.
* Access to or willingness to obtain a Primary care provider at a participating Mayo Clinic site;
* Eligibility determined by ASAM Assessment

Exclusion Criteria:

* Diagnosed personality pathology as the primary presenting concern based on clinical judgment, severe cognitive impairment (e.g., intellectual disability or dementia), or psychosis
* Inability to actively participate in and learn from psychotherapeutic interaction based on clinical evaluation and clinical judgment
* Needing a higher level of mental health care as demonstrated by ASAM32 assessment.
* Decline to answer suicidality questions.
* Already admitted into or about to initiate treatment in another addiction treatment program.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/28/2025. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Tyler Oesterle, M.D., M.P.H.

Open for enrollment

Contact information:

Danielle Cox

(507) 422-1704

Addictionibh@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20583542

Mayo Clinic Footer